Clinical Trial Update: Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessing how tadalafil (Cialis) affects renal function in response to volume expansion in preclinical diastolic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Renal Impairment

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiomyopathy, Renal Impairment | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-21